Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Si-Bone (SIBN) Cash & Equivalents (2017 - 2025)

Si-Bone has reported Cash & Equivalents over the past 9 years, most recently at $33.5 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $33.5 million for Q4 2025, down 4.08% from a year ago — trailing twelve months through Dec 2025 was $33.5 million (down 4.08% YoY), and the annual figure for FY2025 was $33.5 million, down 4.08%.
  • Cash & Equivalents for Q4 2025 was $33.5 million at Si-Bone, up from $26.5 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SIBN hit a ceiling of $93.1 million in Q2 2023 and a floor of $15.6 million in Q1 2023.
  • Median Cash & Equivalents over the past 5 years was $29.8 million (2021), compared with a mean of $35.1 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 414.55% in 2023 and later crashed 72.51% in 2024.
  • Si-Bone's Cash & Equivalents stood at $63.4 million in 2021, then tumbled by 67.33% to $20.7 million in 2022, then rose by 12.62% to $23.3 million in 2023, then surged by 49.79% to $34.9 million in 2024, then dropped by 4.08% to $33.5 million in 2025.
  • The last three reported values for Cash & Equivalents were $33.5 million (Q4 2025), $26.5 million (Q3 2025), and $34.2 million (Q2 2025) per Business Quant data.